• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

离子液体辅助合成塞来昔布:以三(2-羟乙基)乙酸铵为高效可重复使用的催化剂

Ionic Liquid-assisted Synthesis of Celexocib Using Tris-(2-hydroxyethyl) Ammonium Acetate as an Efficient and Reusable Catalyst.

作者信息

Ahfad-Hosseini Hamid Reza, Bagheri Hasan, Amidi Salimeh

机构信息

Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Iran J Pharm Res. 2017 Winter;16(1):158-164.

PMID:28496471
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5423243/
Abstract

Celecoxib is classified as none traditional nonsteroidal anti-inflammatory drugs (NSAIDs). This compound has conventional properties of NSAIDs such as anti-inflammatory, analgesic, and antipyretic activities beside reduced risk of gastrointestinal side effect of traditional NSAIDs such as ibuprofen. This compound gets a second sale rank of NSAIDs market at 2016 in the world and sales more than 17000 Kg in Iran during the past 6 month. So, a simple, rapid and green method for synthesis of this compound is important. In the present study, a novel green method was suggested for the synthesis of celecoxib using the ionic liquid. Celecoxib was provided by the reaction of trifluoroacetone, 4-methylbenzoylchloride, and 4-hydrazinobenzenesulfonamide hydrochloride. The tris-(2-hydroxyethyl) ammonium acetate as ionic liquid was prepared by mixing tris-(2-hydroxyethyl) ammonium and acetic acid, and used as an efficient catalyst. The structure of the synthetic products was confirmed by analytical and spectroscopic methods including HNMR, CNMR, IR, MS and elemental analysis. This ionic liquid can play dual roles in the synthesis of celecoxib, as a catalyst to improve electrophilicity of carbonyl group and also as a solvent of reaction. The reaction rate and yield (86%) were improved considerably. Moreover IL showed the same efficiency when used in 4 consecutive reactions.

摘要

塞来昔布被归类为非传统非甾体抗炎药(NSAIDs)。该化合物具有NSAIDs的常规特性,如抗炎、镇痛和解热活性,同时降低了传统NSAIDs(如布洛芬)胃肠道副作用的风险。该化合物在2016年全球NSAIDs市场中排名第二,在过去6个月中,伊朗的销量超过17000千克。因此,开发一种简单、快速且绿色的该化合物合成方法具有重要意义。在本研究中,提出了一种使用离子液体合成塞来昔布的新型绿色方法。塞来昔布是由三氟丙酮、4-甲基苯甲酰氯和4-肼基苯磺酰胺盐酸盐反应制得。通过将三(2-羟乙基)铵与乙酸混合制备了三(2-羟乙基)乙酸铵离子液体,并将其用作高效催化剂。通过HNMR、CNMR、IR、MS和元素分析等分析和光谱方法对合成产物的结构进行了确证。这种离子液体在塞来昔布的合成中可发挥双重作用,既作为提高羰基亲电性的催化剂,又作为反应溶剂。反应速率和产率(86%)得到了显著提高。此外,该离子液体在连续4次反应中使用时表现出相同的效率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/910e/5423243/13dababec59c/ijpr-16-158-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/910e/5423243/7bd78f8dff45/ijpr-16-158-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/910e/5423243/27b8d279376b/ijpr-16-158-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/910e/5423243/e4256764721d/ijpr-16-158-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/910e/5423243/8b5160999cce/ijpr-16-158-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/910e/5423243/13dababec59c/ijpr-16-158-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/910e/5423243/7bd78f8dff45/ijpr-16-158-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/910e/5423243/27b8d279376b/ijpr-16-158-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/910e/5423243/e4256764721d/ijpr-16-158-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/910e/5423243/8b5160999cce/ijpr-16-158-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/910e/5423243/13dababec59c/ijpr-16-158-g005.jpg

相似文献

1
Ionic Liquid-assisted Synthesis of Celexocib Using Tris-(2-hydroxyethyl) Ammonium Acetate as an Efficient and Reusable Catalyst.离子液体辅助合成塞来昔布:以三(2-羟乙基)乙酸铵为高效可重复使用的催化剂
Iran J Pharm Res. 2017 Winter;16(1):158-164.
2
A Simple and Efficient Synthesis of 4-Arylacridinediones and 6-Aryldiindeno[1,2-b:2,1-e]pyridinediones using CuI Nanoparticles as Catalyst under Solvent-Free Conditions.在无溶剂条件下使用碘化亚铜纳米颗粒作为催化剂简单高效地合成4-芳基吖啶二酮和6-芳基二茚并[1,2-b:2,1-e]吡啶二酮
Comb Chem High Throughput Screen. 2017;20(9):773-780. doi: 10.2174/1386207320666171002123027.
3
Comparative Analgesic Effects of Ibuprofen, Celecoxib and Tramadol after third Molar Surgery: A Randomized Double Blind Controlled Trial.布洛芬、塞来昔布和曲马多在第三磨牙手术后的镇痛效果比较:一项随机双盲对照试验
J Contemp Dent Pract. 2018 Nov 1;19(11):1334-1340.
4
Reaction of pharmacological active tris-(2-hydroxyethyl)ammonium 4-chlorophenylsulfanylacetate with ZnCl2 or NiCl2: first conversion of a protic ionic liquid into metallated ionic liquid.药理活性的三(2-羟乙基)铵4-氯苯硫基乙酸酯与ZnCl₂ 或NiCl₂ 的反应:质子离子液体首次转化为金属化离子液体。
Chem Cent J. 2013 Feb 19;7(1):34. doi: 10.1186/1752-153X-7-34.
5
Preparation and Characterization of a Novel Room Temperature Dicationic Ionic Liquid and its Application in the Synthesis of Xanthenediones Under Solvent-Free Conditions.一种新型室温双阳离子离子液体的制备、表征及其在无溶剂条件下合成呫吨二酮中的应用。
Comb Chem High Throughput Screen. 2018;21(8):602-608. doi: 10.2174/1386207321666181106114848.
6
Penetration and pharmacokinetics of non-steroidal anti-inflammatory drugs in rat prostate tissue.非甾体抗炎药在大鼠前列腺组织中的渗透及药代动力学
Prostate. 2018 Feb;78(2):80-85. doi: 10.1002/pros.23447. Epub 2017 Nov 6.
7
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.塞来昔布与非甾体抗炎药治疗骨关节炎和类风湿关节炎的胃肠道毒性:CLASS研究:一项随机对照试验。塞来昔布长期关节炎安全性研究。
JAMA. 2000 Sep 13;284(10):1247-55. doi: 10.1001/jama.284.10.1247.
8
Synthesis of some Novel Imidazoles Catalyzed by Co3O4 Nanoparticles and Evaluation of their Antibacterial Activities.Co3O4纳米颗粒催化合成一些新型咪唑及其抗菌活性评估
Comb Chem High Throughput Screen. 2018;21(4):271-280. doi: 10.2174/1386207321666180330164942.
9
Aryl/heteroaryl Substituted Celecoxib Derivatives as COX-2 Inhibitors: Synthesis, Anti-inflammatory Activity and Molecular Docking Studies.芳基/杂芳基取代的塞来昔布衍生物作为COX-2抑制剂:合成、抗炎活性及分子对接研究
Med Chem. 2017;13(5):484-497. doi: 10.2174/1573406413666170221093740.
10
Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.环氧化酶-2选择性非甾体抗炎药(依托度酸、美洛昔康、塞来昔布、罗非昔布、艾瑞昔布、伐地昔布和鲁米昔布)用于骨关节炎和类风湿性关节炎:系统评价与经济学评估
Health Technol Assess. 2008 Apr;12(11):1-278, iii. doi: 10.3310/hta12110.

本文引用的文献

1
Celecoxib Treatment Alters p53 and MDM2 Expression via COX-2 Crosstalk in A549 Cells.塞来昔布治疗通过COX-2串扰改变A549细胞中p53和MDM2的表达。
Iran J Pharm Res. 2016 Spring;15(2):483-9.
2
Simultaneous Determination of Diosmin and Hesperidin in Pharmaceuticals by RPLC using Ionic Liquids as Mobile Phase Modifiers.使用离子液体作为流动相改性剂的反相液相色谱法同时测定药品中的地奥司明和橙皮苷
Iran J Pharm Res. 2016 Winter;15(1):141-8.
3
Amides of non-steroidal anti-inflammatory drugs with thiomorpholine can yield hypolipidemic agents with improved anti-inflammatory activity.
非甾体抗炎药与硫代吗啉的酰胺可产生具有改善抗炎活性的降血脂药物。
Bioorg Med Chem Lett. 2016 Feb 1;26(3):910-913. doi: 10.1016/j.bmcl.2015.12.063. Epub 2015 Dec 19.
4
A Randomized, Double-blind, Placebo-controlled Trial of Celecoxib Augmentation of Sertraline in Treatment of Drug-naive Depressed Women: A Pilot Study.塞来昔布增强舍曲林治疗初治抑郁女性的随机、双盲、安慰剂对照试验:一项初步研究
Iran J Pharm Res. 2015 Summer;14(3):891-9.
5
Celecoxib Up Regulates the Expression of Drug Efflux Transporter ABCG2 in Breast Cancer Cell Lines.塞来昔布上调乳腺癌细胞系中药物外排转运体ABCG2的表达。
Iran J Pharm Res. 2014 Fall;13(4):1393-401.
6
Preparation and characterization of celecoxib dispersions in soluplus(®): comparison of spray drying and conventional methods.塞来昔布在固体分散体Solupuls®中的制备与表征:喷雾干燥法与传统方法的比较
Iran J Pharm Res. 2015 Winter;14(1):35-50.
7
Regulating impurities in pharmaceutical products: a tolerability of risk approach?药品杂质的监管:风险可接受性方法?
Expert Rev Clin Pharmacol. 2008 Mar;1(2):241-50. doi: 10.1586/17512433.1.2.241.
8
Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships.选择性环氧化酶-2抑制剂:其构效关系综述
Iran J Pharm Res. 2011 Fall;10(4):655-83.
9
Celecoxib analogs that lack COX-2 inhibitory function: preclinical development of novel anticancer drugs.缺乏COX - 2抑制功能的塞来昔布类似物:新型抗癌药物的临床前开发
Expert Opin Investig Drugs. 2008 Feb;17(2):197-208. doi: 10.1517/13543784.17.2.197.
10
Cyclooxygenases in hepatocellular carcinoma.肝细胞癌中的环氧化酶
World J Gastroenterol. 2006 Aug 28;12(32):5113-21. doi: 10.3748/wjg.v12.i32.5113.